PTH and Mineralization: Role of Matrix Gla Protein

PTH 和矿化:基质 Gla 蛋白的作用

基本信息

  • 批准号:
    6905644
  • 负责人:
  • 金额:
    $ 7.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mineralization of bone and teeth is a complex process controlled by the interplay between various nucleators and inhibitors of hydroxyapatite crystal formation. Among these proteins, matrix Gla protein (MGP) is the most important with in vivo evidence for a role in regulating mineralization. Recently, we showed that MGP is induced by parathyroid hormone (PTH), and this response might play a crucial role in PTH-mediated inhibition of mineralization in osteoblasts. However, the transcriptional mechanisms involved in PTH regulation of MGP are not known. Detailed knowledge of this regulation will help in understanding a factor that can be used as a target for preventive and therapeutic interventions for patients with mineralization defects. The overall goal of this project is to use genetic and molecular approaches to determine the importance of MGP in the regulation of osteoblast mineralization by PTH; and to determine the transcriptional mechanisms involved in this regulation. This project will test two hypotheses: (a) induction of MGP is responsible for the inhibition of mineralization seen in osteoblasts following parathyroid hormone treatment, and (b) stimulation of MGP is mediated through activation of second messenger(s) which regulate specific cis-acting response elements in the promoter of the MGP gene. The following two specific aims will be pursued: 1. Determine the response of Mgp-deficient or -suppressed osteoblasts to parathyroid hormone treatment, and 2. Identify the DNA response elements necessary for MGP responsiveness to parathyroid hormone in osteoblasts. Aim 1 will use both Mgp-deficient (Mgp -/-) mice and osteoblasts in which MGP synthesis is suppressed using RNAi to determine the regulation of mineralization by PTH. We expect that PTH treatment of MGP-deficient/suppressed osteoblasts will not inhibit mineralization. Aim 2 will characterize the MGP promoter to understand the regulatory mechanisms involved in PTH induction. We expect, based on our preliminary data that CRE and AP-1 sites are key to PTH induced transcription of MGP. Our long-range goal, which will be tested in a future R01 application, is to characterize specific transcriptional factors involved in PTH-mediated regulation of MGP, and perform detailed structure-function analyses of MGP as it relates to PTH-mediated inhibition of mineralization.
描述(申请人提供):骨和牙齿的矿化是一个复杂的过程,由羟基磷灰石晶体形成的各种成核剂和抑制剂之间的相互作用控制。在这些蛋白质中,基质GLA蛋白(MGP)是最重要的,有体内证据表明它在调节矿化中起到了作用。最近,我们发现甲状旁腺激素(PTH)诱导MGP,这种反应可能在PTH介导的成骨细胞矿化抑制中起关键作用。然而,参与MGP甲状旁腺激素调控的转录机制尚不清楚。对这一规则的详细了解将有助于理解可用作矿化缺陷患者预防和治疗干预目标的因素。本项目的总体目标是使用遗传学和分子方法来确定MGP在甲状旁腺素调节成骨细胞矿化中的重要性,并确定参与这一调节的转录机制。本项目将验证两个假说:(A)甲状旁腺激素治疗后MGP的诱导与成骨细胞矿化的抑制有关,(B)MGP的刺激是通过第二信使(S)的激活而介导的,第二信使调节MGP基因启动子中特定的顺式作用反应元件。我们将追求以下两个目标:1.确定MGP缺陷或抑制的成骨细胞对甲状旁腺激素治疗的反应;2.确定成骨细胞中MGP对甲状旁腺激素反应所必需的DNA反应元件。目的1将利用MGP缺陷(MGP-/-)小鼠和使用RNAi抑制MGP合成的成骨细胞来确定甲状旁腺素对矿化的调节。我们预计甲状旁腺素对MGP缺失/抑制的成骨细胞的治疗不会抑制矿化。目的2研究MGP启动子的特性,以了解甲状旁腺激素诱导的调控机制。根据我们的初步数据,我们预计Cre和AP-1位点是PTH诱导MGP转录的关键。我们的长期目标将在未来的R01应用中进行测试,我们的长期目标是表征参与PTH介导的MGP调控的特定转录因子,并对MGP进行详细的结构功能分析,因为它与PTH介导的矿化抑制有关。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of matrix Gla protein by parathyroid hormone in MC3T3-E1 osteoblast-like cells involves protein kinase A and extracellular signal-regulated kinase pathways.
MC3T3-E1 成骨细胞样细胞中甲状旁腺激素对基质 Gla 蛋白的调节涉及蛋白激酶 A 和细胞外信号调节激酶途径。
  • DOI:
    10.1002/jcb.21314
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Suttamanatwong,Supaporn;Franceschi,RennyT;Carlson,AnnE;Gopalakrishnan,Rajaram
  • 通讯作者:
    Gopalakrishnan,Rajaram
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAJARAM GOPALAKRISHNAN其他文献

RAJARAM GOPALAKRISHNAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAJARAM GOPALAKRISHNAN', 18)}}的其他基金

Role of Twisted Gastrulation in Osteoclastogenesis
扭曲原肠胚形成在破骨细胞生成中的作用
  • 批准号:
    8453487
  • 财政年份:
    2010
  • 资助金额:
    $ 7.18万
  • 项目类别:
Periodontal Disease as a Risk Factor for ONJ
牙周病是 ONJ 的危险因素
  • 批准号:
    8109247
  • 财政年份:
    2010
  • 资助金额:
    $ 7.18万
  • 项目类别:
Periodontal Disease as a Risk Factor for ONJ
牙周病是 ONJ 的危险因素
  • 批准号:
    7788281
  • 财政年份:
    2010
  • 资助金额:
    $ 7.18万
  • 项目类别:
Role of Twisted Gastrulation in Osteoclastogenesis
扭曲原肠胚形成在破骨细胞生成中的作用
  • 批准号:
    8088173
  • 财政年份:
    2010
  • 资助金额:
    $ 7.18万
  • 项目类别:
Role of Twisted Gastrulation in Osteoclastogenesis
扭曲原肠胚形成在破骨细胞生成中的作用
  • 批准号:
    7888320
  • 财政年份:
    2010
  • 资助金额:
    $ 7.18万
  • 项目类别:
Role of Twisted Gastrulation in Osteoclastogenesis
扭曲原肠胚形成在破骨细胞生成中的作用
  • 批准号:
    8651421
  • 财政年份:
    2010
  • 资助金额:
    $ 7.18万
  • 项目类别:
Role of Twisted Gastrulation in Osteoclastogenesis
扭曲原肠胚形成在破骨细胞生成中的作用
  • 批准号:
    8240980
  • 财政年份:
    2010
  • 资助金额:
    $ 7.18万
  • 项目类别:
PTH and Mineralization: Role of Matrix Gla Protein
PTH 和矿化:基质 Gla 蛋白的作用
  • 批准号:
    6812291
  • 财政年份:
    2004
  • 资助金额:
    $ 7.18万
  • 项目类别:

相似海外基金

Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
  • 批准号:
    23K10830
  • 财政年份:
    2023
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10539405
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10688080
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
  • 批准号:
    DP220101361
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10677770
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
  • 批准号:
    RGPIN-2019-04411
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
  • 批准号:
    2143019
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
  • 批准号:
    486535
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10330828
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
  • 批准号:
    2046602
  • 财政年份:
    2021
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了